Denosumab

Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures. Denosumab also has anti-cancer activity.


Cat. No.: EX-A7007	Purity: >98%

	Chemical structure of Denosumab

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
5mg	785	In-stock
10mg	1185	In-stock
25mg	get quote	In-stock
50mg	get quote	In-stock
100mg	get quote	In-stock
200mg	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Immunoglobulin G2
Synonyms 2	Ranmark
CAS No.	615258-40-7
Purity	>98%
Formula	C6404H9908N1724O2004S50
Mol Weight	144716.86
Color	colorless to light yellow (sol
State	liquid
Storage	Store at 4℃, Do not freeze
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Moen MD, et al. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging. 2011;28(1):63-82. [2]. Chawla S, et al. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol. 2019;20(12):1719-1729.
CoA	CoA of Denosumab


		Search